MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credit: AI
Propranolol is a beta-blocker that is used to address certain heart conditions and physical symptoms of anxiety. It has been gaining attention on social media for calming nerves before stressful life events like job interviews, presentations and other similar situations.
However, experts warn that its surging popularity may make it difficult to pay attention to the limited evidence supporting its use for anxiety.
The medication works by blocking the effects of adrenaline on beta receptors, slowing the heart rate and reducing physical symptoms like trembling, sweating and palpitations. It does not directly treat the emotional symptoms of anxiety.
In England, the NHS dispensed around 8.4 million propranolol prescription items in the 12 months leading up to June 2026, a 4.7% increase from the previous year. These figures cover all uses of the drug, not just anxiety.
Significant increases in prescriptions among younger women and teenage girls over a decade was also seen. Social media has helped promote propranolol as a quick fix for nerves, but its popularity does not reflect the strength of its clinical evidence.
Also read: Seasonal Depression & Anhedonia: How Winter Can Affect Pleasure And Motivation
Dr Daniel Gordon, private GP and managing director at DGA Health told Daily Mail that propranolol may help people whose anxiety mainly causes physical symptoms.
"In my experience, the people who find propranolol helpful are usually those whose anxiety shows up mostly in the body, with palpitations, shaking and a pounding chest," Dr Gordon said.
He also said that addressing those symptoms can treat physical symptoms, helping people feel more in control. But feeling calmer in the body is not the same as treating anxiety, and for many people talking therapies, and sometimes other medicines, prove to be helpful.
Additionally, the evidence available on Propranolol is insufficient contrary to its online popularity. A systematic review of eight small randomised trials, covering around 200 people, concluded that the evidence was insufficient to support routine use of propranolol in any anxiety disorder.
Some people do report relief of physical symptoms, but propranolol us not recommended for anxiety as there are no modern, reliable clinical trials.
Dr Gordon added, "This is exactly why proper assessment matters. Propranolol should generally not be used by people with asthma, certain heart rhythm problems such as heart block, a very slow heart rate or low blood pressure, and it can mask the warning signs of low blood sugar in people with diabetes."
Common side effects of propranolol include dizziness, tiredness, cold hands and feet, and sleep disturbances. Because propranolol can decrease heart rate and blood pressure, it may be unsuitable for people with low blood pressure. It can also be risky for people with asthma and heart conditions.
Buying prescription medication online is not inherently unsafe, but a brief questionnaire does not necessarily mean that a person's medical history and individual risks have been adequately assessed.
Gordon stressed that a medical doctor needs to review a patient's medical history before prescribing the drug as it can interact with other medications and may be unsuitable for some patients.
Propranolol may help some people manage physical symptoms in some situations, but it is not a substitute for treating clinical anxiety.
Psychological therapies, including cognitive behavioural therapy (CBT), can help people manage anxious thoughts. Medication may also be appropriate depending on the person's symptoms.
People whose anxiety affects their work, relationships or daily activities should speak to a healthcare professional rather than taking propranolol.
Credit: iStock
Police in Guinea-Bissau raided the Bandim Health Project on Monday, October 19, and seized a batch of hepatitis B vaccines intended for a controversial trial involving 14,000 newborns, according to an official statement.
The project’s Danish researchers, Peter Aaby and Christine Stabell Benn, are at the center of the dispute. The study received $1.6 million from the US Centers for Disease Control and Prevention (CDC), matched by the Pershing Square Foundation and the Bluebell Foundation, bringing total funding to $3.2 million. US Health and Human Services Secretary Robert F. Kennedy Jr. has praised the researchers’ work.
The police search took place on Monday, involving “investigative procedures aimed at clarifying the circumstances related to the said batch of vaccines”, according to the social media post, which was translated from Portuguese. The announcement noted that seizing the immunizations did not point to “irregularities in the quality, safety, or effectiveness of the vaccines”, The Guardian reported.
The proposed trial would randomly divide 14,000 newborns into two groups: one would receive the hepatitis B vaccine at birth, while the other would receive it six weeks later.
The WHO recommends hepatitis B vaccination within 24 hours of birth to prevent mother-to-child transmission.
Also read: Hepatitis B Infections Could Rise 83% If US Changes Newborn Vaccine Policy: Study
Hepatitis B is highly endemic in Guinea-Bissau, affecting more than 12% of adults. Infants infected at birth have about a 90% chance of developing chronic infection, which can lead to cirrhosis, liver failure and liver cancer.
Stig Børsen Hansen, a member of the University of Southern Denmark’s ethics committee, resigned after the committee narrowly approved the updated protocol. He warned that the trial would expose some newborns to potentially serious infections by delaying vaccination.
Rather than testing the vaccine’s established efficacy, the study aims to investigate the proposed “non-specific effects” of vaccines — potential health effects beyond protection against targeted infections.
Critics argue that delaying a recommended birth dose to investigate these hypotheses exposes newborns to avoidable risks. Former Guinea-Bissau Health Minister Magda Robalo and other critics have also raised concerns about conducting such research in a vulnerable population.
The Bandim Health Project published an approval letter from Guinea-Bissau’s national ethics committee, dated July 14. A Danish research ethics committee also approved the study earlier this month.
However, transitional government Health Minister Quinhin Nantote disputed reports that the trial would proceed, telling The Guardian: “This is not even remotely true.”
WHO spokesperson Tarik Jašarević said a study denying newborns the vaccine would be “unethical” and expose them to “serious and potentially irreversible harm.” The WHO is advising Guinea-Bissau’s Ministry of Health on introducing the vaccine and assessing the study’s potential impact.
Anthropologist Peter Aaby founded the Bandim Health Project in 1978. It is now co-led by his wife, epidemiologist Christine Stabell Benn.
Kennedy has called the pair “the deities of vaccine research” at an anti-vaccine conference and cited their research on the diphtheria-tetanus-pertussis (DTP) vaccine. A subsequent study by the researchers produced different results.
Kennedy also called Aaby a “very famous” researcher on Joe Rogan’s podcast in 2023 and cited his work when he halted US funding to Gavi, the Vaccine Alliance.
Stabell Benn served on the hepatitis B working group of the US Advisory Committee on Immunization Practices (ACIP) and presented evidence before the committee voted to end the universal hepatitis B birth-dose recommendation. A federal judge subsequently stayed the decision.
Credit: Times Network
With digital innovation, expanding healthcare access, and a growing focus on self-reliance driving transformation in India's healthcare sector, the Times Network India Health Summit & Awards 2026 is set to return for its third edition.
The event, to be held on October 28th, will bring together policymakers, healthcare leaders, clinicians, researchers, innovators, and industry stakeholders to discuss the future of India's healthcare ecosystem.
Centered on the theme, “The Blueprint for a Future-Ready Healthcare Ecosystem – Innovation. Access. Self-Reliance,” the summit will explore emerging healthcare innovations, collaborations, and policy approaches, culminating in an awards ceremony recognizing excellence across the sector.
As India is advancing in artificial intelligence (AI), digital health, biotechnology, medical technology (MedTech), and indigenous manufacturing, these areas will also be central to discussions on strengthening the country's healthcare ecosystem.
Anupriya Patel, Union Minister of State for Health and Family Welfare and Minister of State for Chemicals and Fertilizers, is expected to attend as the chief guest.
The second edition of the Times Network India Health Summit & Awards 2026 will feature:
The summit will feature six panel discussions covering key areas of healthcare innovation, access, and policy.
The summit is being held in association with Onextel Communications Media, co-powered by Novartis and supported by HealthandMe. It will conclude with a felicitation ceremony recognizing excellence across the healthcare sector.
© $2026 Times Horizon Private Limited